Ocular Therapeutix (OCUL) Gross Profit (2014 - 2026)
Ocular Therapeutix (OCUL) recorded Gross Profit of $11.46 million in Q2 2026, down 0.4% from $11.52 million a year earlier but up 21.2% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Gross Profit (2014 - 2026) Analysis & Trends
On a TTM basis, Ocular Therapeutix's Gross Profit came in at $45.35 million as of Jun 30, 2026, down 10.5% year-over-year; for FY2025, it was $45.38 million, down 21.9% from FY2024.
- Annual Gross Profit has a five-year compound annual growth rate of 24.3% (FY2020 to FY2025).
- Across earlier years, Gross Profit came in at $58.1 million in FY2024 (+9.3%), $53.16 million in FY2023 (+13.2%), $46.95 million in FY2022 (+20.0%) and $39.12 million in FY2021 (+155.3%).
- Quarterly Gross Profit has ranged from $9.44 million in Q1 2025 to $15.85 million in Q4 2024 over the past five years.
- On a year-over-year basis, Gross Profit rose in three of the last eight quarters, with an average decline of 8.5%.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 99.8% in Q3 2021, against a decline of 29.8% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $9.46 million (Q1 2026), $11.66 million (Q4 2025) and $12.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.46 Mn |
| Mar 31, 2026 | 9.46 Mn |
| Dec 31, 2025 | 11.66 Mn |
| Sep 30, 2025 | 12.77 Mn |
| Jun 30, 2025 | 11.52 Mn |
| Mar 31, 2025 | 9.44 Mn |
| Dec 31, 2024 | 15.85 Mn |
| Sep 30, 2024 | 13.86 Mn |
| Jun 30, 2024 | 14.93 Mn |
| Mar 31, 2024 | 13.45 Mn |
| Dec 31, 2023 | 13.42 Mn |
| Sep 30, 2023 | 13.70 Mn |
| Jun 30, 2023 | 13.88 Mn |
| Mar 31, 2023 | 12.16 Mn |
| Dec 31, 2022 | 13.06 Mn |
| Sep 30, 2022 | 10.89 Mn |
| Jun 30, 2022 | 11.11 Mn |
| Mar 31, 2022 | 11.89 Mn |
| Dec 31, 2021 | 11.20 Mn |
| Sep 30, 2021 | 10.84 Mn |
API Access
Ocular Therapeutix Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();